Literature DB >> 3169487

Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin.

W L Peterson1, E Lee, M Feldman.   

Abstract

Endoscopic and microscopic appearances of antral and fundic mucosa were correlated with the presence or absence of Campylobacter pylori--and with plasma immunoglobulin G antibodies to that organism--in 23 healthy volunteers, 12 of whom had received indomethacin and 11 of whom had received no medication. Antral C. pylori, found in 9 of 23 biopsy specimens (3 of 11 controls, 6 of 12 indomethacin-treated patients; not significantly different), correlated strongly with histologic evidence of active superficial antral gastritis (p less than 0.005), but not with the endoscopic appearance of the antrum. In contrast to the antrum, fundic C. pylori, found in 14 of 23 biopsy specimens (61%), were frequently associated with histologically and endoscopically normal fundic mucosa. Campylobacter pylori-associated active antral gastritis occurred only in subjects whose fundus harbored this organism. Plasma immunoglobulin G antibody titers to C. pylori were highest in subjects with Campylobacter-associated antral gastritis and lowest in subjects without gastric Campylobacter. These studies suggest that healthy humans may harbor C. pylori in their proximal stomach without apparent ill effects. In some of these individuals, the organism also involves the antrum and is associated with active gastritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169487     DOI: 10.1016/0016-5085(88)90349-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

Review 2.  Peptic ulcer--an infectious disease?

Authors:  W L Peterson
Journal:  West J Med       Date:  1990-02

3.  Campylobacter pylori in alcoholic hemorrhagic "gastritis".

Authors:  L Laine; M Marin-Sorensen; W M Weinstein
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

4.  Gastric juice ammonia vs CLO test for diagnosis of Helicobacter pylori infection.

Authors:  D H Yang; H S Bom; Y E Joo; S K Choi; J S Rew; C M Yoon
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

5.  Diagnostic efficiency of an ultrarapid endoscopy room test for Helicobacter pylori.

Authors:  A V Thillainayagam; A S Arvind; R S Cook; I G Harrison; S Tabaqchali; M J Farthing
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

6.  Effects of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose.

Authors:  A A Rabassa; R Goodgame; F M Sutton; C N Ou; C Rognerud; D Y Graham
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection.

Authors:  C J McCarthy; M McDermott; D Hourihane; C O'Morain
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

8.  Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers.

Authors:  A V Thillainayagam; S Tabaqchali; S J Warrington; M J Farthing
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

9.  Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.

Authors:  K Shah; A B Price; I C Talbot; K D Bardhan; C G Fenn; I Bjarnason
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

10.  Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens.

Authors:  L Santucci; S Fiorucci; L Patoia; F M Di Matteo; P M Brunori; A Morelli
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.